A deleterious role for Th9/IL-9 in hepatic fibrogenesis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Qin, Shan Yu ^a   Lu, Dong Hong ^a   Guo, Xiao Yun ^a   Luo, Wei ^a   Hu, Bang Li ^a   Huang, Xiao Li ^a   Chen, Mei ^a   Wang, Jia Xu ^a   Ma, Shi Jia ^a   Yang, Xian Wen ^a   Jiang, Hai Xing ^a   Zhou, You ^b,c  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 17; INTERLEUKIN 9; MESSENGER RNA; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ADOLESCENT; ADULT; AGED; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CASE CONTROL STUDY; CHRONIC HEPATITIS B; COMPLICATION; DISEASE MODEL; FEMALE; GENETICS; HELPER CELL; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; LIVER CIRRHOSIS; LYMPHOCYTE COUNT; MALE; METABOLISM; MIDDLE AGED; MOUSE; PATHOLOGY; SPLEEN; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; CASE-CONTROL STUDIES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HEPATITIS B, CHRONIC; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-17; INTERLEUKIN-9; LIVER CIRRHOSIS; LYMPHOCYTE COUNT; MALE; MICE; MIDDLE AGED; RNA, MESSENGER; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TH17 CELLS; YOUNG ADULT;

EID: 84953204297     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18694     Document Type: Article

References (49)

1. Friedman, S. L. Mechanisms of hepatic fibrogenesis. Gastroenterology 134, 1655-69 (2008).
2. Hashimoto, N. et al. Modulation of CD4(+) T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis. Clin Exp Immunol 165, 243-50 (2011).
3. Heymann, F. et al. Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice. Hepatology 55, 898-909 (2012).
4. Iredale, J. P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117, 539-48 (2007).
5. Karlmark, K. R. et al. Chemokine-directed immune cell infiltration in acute and chronic liver disease. Expert Rev Gastroenterol Hepatol 2, 233-242 (2008).
6. Niu, Y. et al. The balance between intrahepatic IL-17(+) T cells and Foxp3(+) regulatory T cells plays an important role in HBV-related end-stage liver disease. BMC Immunol 12, 47 (2011).
7. Zhang, J. Y. et al. Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment. PLoS One 5, e13869 (2010).
8. Marra, F. et al. Mononuclear cells in liver fibrosis. Semin Immunopathol 31, 345-58 (2009).
9. Li, H. et al. IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system. Eur J Immunol 41, 2197-206 (2011).
10. Noelle, R. J. & Nowak, E. C. Cellular sources and immune functions of interleukin-9. Nat Rev Immunol 10, 683-7 (2010).
11. Soroosh, P. & Doherty, T. A. Th9 and allergic disease. Immunology 127, 450-8 (2009).
12. Jager, A. & Kuchroo, V. K. Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol 72, 173-84 (2010).
13. Mucida, D. & Cheroutre, H. The many face-lifts of CD4 T helper cells. Adv Immunol 107, 139-52 (2010).
14. Wan, Y. Y. Multi-tasking of helper T cells. Immunology 130, 166-71 (2010).
15. Li, H. & Rostami, A. IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity. J Neuroimmune Pharmacol 5, 198-209 (2010).
16. Nowak, E. C. et al. IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med 206, 1653-60 (2009).
17. Smith, S. E. et al. Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses. Cancer Immunol Immunother 60, 1775-87 (2011).
18. Sun, X. F. et al. Impaired balance of T helper 17/T regulatory cells in carbon tetrachloride-induced liver fibrosis in mice. World J Gastroenterol 20, 2062-70 (2014).
19. Tan, Z. et al. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation. J Immunol 191, 1835-44 (2013).
20. Chen, T. et al. Protective effect of platycodin D on liver injury in alloxan-induced diabetic mice via regulation of Treg/Th17 balance. Int Immunopharmacol 26, 338-48 (2015).
21. Weng, H. L. et al. IFN-gamma inhibits liver progenitor cell proliferation in HBV-infected patients and in 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet-fed mice. J Hepatol 59, 738-45 (2013).
22. Wei, L. et al. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J Biol Chem 282, 34605-10 (2007).
23. Coquet, J. M. et al. Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J Immunol 180, 7097-101 (2008).
24. Liao, W. et al. Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression. Proc Natl Acad Sci USA 111, 3508-13 (2014).
25. Nalleweg, N. et al. IL-9 and its receptor are predominantly involved in the pathogenesis of UC. Gut. 5, 743-55 (2014).
26. Ming, D. et al. Elevated TGF-beta1/IL-31 Pathway Is Associated with the Disease Severity of Hepatitis B Virus-Related Liver Cirrhosis. Viral Immunol 28, 209-16 (2015).
27. Li, H. et al. Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population. J Immunol 185, 4095-100 (2010).
28. Kearley, J. et al. IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am J Respir Crit Care Med 183, 865-75 (2011).
29. Ge, J. et al. Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol 30, 60-7 (2010).
30. Sun, H. Q. et al. Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis. J Viral Hepat 19, 396-403 (2012).
31. Longhi, M. S. et al. Inhibition of interleukin-17 promotes differentiation of CD25(-) cells into stable T regulatory cells in patients with autoimmune hepatitis. Gastroenterology 142, 1526-35 e1526 (2012).
32. Elyaman, W. et al. IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci U S A 106, 12885-90 (2009).
33. Nowak, E. C. & Noelle, R. J. Interleukin-9 as a T helper type 17 cytokine. Immunology 131, 169-73 (2010).
34. Stephens, G. L. et al. IL-9 is a Th17-derived cytokine that limits pathogenic activity in organ-specific autoimmune disease. Eur J Immunol 41, 952-62 (2011).
35. Yang, Y. et al. Astaxanthin prevents TGFbeta1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells. Biochim Biophys Acta 1850, 178-85 (2015).
36. Meng, F. et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 143, 765-76 e761-763 (2012).
37. Li, J., Qiu, S. J. et al. Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis. PLoS One 7, e39307 (2012).
38. Xu, R. et al. Neutralization of interleukin-17 attenuates high fat diet-induced non-alcoholic fatty liver disease in mice. Acta Biochim Biophys Sin (Shanghai) 45, 726-33 (2013).
39. van den Brule, S. et al. Profibrotic effect of IL-9 overexpression in a model of airway remodeling. Am J Respir Cell Mol Biol 37, 202-9 (2007).
40. Arras, M. et al. Interleukin-9 reduces lung fibrosis and type 2 immune polarization induced by silica particles in a murine model. Am J Respir Cell Mol Biol 24, 368-75 (2001).
41. Yamasaki, A. et al. IL-9 induces CCL11 expression via STAT3 signalling in human airway smooth muscle cells. PLoS One 5, e9178 (2010).
42. Hong, C. H. et al. IL-9 induces IL-8 production via STIM1 activation and ERK phosphorylation in epidermal keratinocytes: A plausible mechanism of IL-9R in atopic dermatitis. J Dermatol Sci 78, 206-14 (2015).
43. Iwamoto, S. et al. TNF-alpha drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses. J Immunol 179, 1449-57 (2007).
44. Veldhoen, M. et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179-89 (2006).
45. Zhou, L. et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8, 967-74 (2007).
46. Dardalhon, V. et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 9, 1347-55 (2008).
47. Veldhoen, M. et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 9, 1341-6 (2008).
48. Wong, M. T. et al. Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol Cell Biol 88, 624-31 (2010).
49. Putheti, P. et al. Human CD4 memory T cells can become CD4+ IL-9+ T cells. PLoS One 5, e8706 (2010).